FDA Approves Second Booster For Older Adults, Some Immunocompromised People
@WSJ4 years ago
Pfizer and BioNTech plan to ask health regulators soon to authorize their Covid-19 vaccine, after more data show it is working safely. If the FDA gives a thumbs-up, the shot would be the first to go into use in the U.S. Here’s what we know and don’t know. on.wsj.com
@WSJ4 years ago
The U.S. bought 200 million additional Covid-19 vaccine doses from Pfizer Inc. and partner BioNTech SE at about $24 a shot, above the $19.50 price of previous deals on.wsj.com
@snopes.com4 years ago
Moderna Says Its COVID-19 Shot Works in Kids As Young As 12
@WSJ4 years ago
The FDA is set to release analyses of the Pfizer-BioNTech vaccine, the first Covid-19 shot being considered for U.S. distribution on.wsj.com
